Valuation: Mega Lifesciences

Market Cap 32.91B 980M 858M 792M 729M 1.37B 94.39B 1.41B 9.46B 3.72B 46.22B 3.68B 3.6B 161B P/E 2026 *
14.2x
P/E 2027 * 13.4x
Enterprise Value 28.3B 843M 738M 681M 627M 1.18B 81.16B 1.21B 8.13B 3.2B 39.74B 3.17B 3.1B 138B EV / Sales 2026 *
1.9x
EV / Sales 2027 * 1.8x
Free-Float
38.61%
Yield 2026 *
4.63%
Yield 2027 * 4.97%
1 day-0.66%
1 week+2.03%
Current month+2.72%
1 month+5.59%
3 months+14.39%
6 months+7.09%
Current year+12.69%
1 week 36.75
Extreme 36.75
38.5
1 month 34
Extreme 34
38.5
Current year 31.5
Extreme 31.5
40
1 year 27.75
Extreme 27.75
40
3 years 24.3
Extreme 24.3
46.75
5 years 24.3
Extreme 24.3
56.5
10 years 15.9
Extreme 15.9
56.5
Manager TitleAgeSince
Chief Executive Officer 64 31/12/1987
Director of Finance/CFO 61 31/12/1996
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 61 31/12/1997
Director/Board Member 64 31/12/2012
Director/Board Member 73 31/01/2013
Date Insider Type Main position Quantity % Market Cap.
29/04/25 Buy

Chief Executive Officer

100,000 0.0115%
28/04/25 Buy

Chief Executive Officer

150,000 0.0172%
28/04/25 Buy

Chief Executive Officer

150,000 0.0172%
Change 5-day change 1-year change 3-year change Capi.($)
-0.66%+2.03%+33.63%-2.58% 979M
+0.85%-0.80%+52.79%+161.33% 1,051B
+1.23%-1.53%+54.58%+59.08% 609B
+0.04%+2.58%+34.47%+86.33% 450B
+0.78%-0.71%+29.28%+24.10% 330B
+1.41%+0.58%+35.44%+40.67% 284B
-0.27%-1.87%+22.34%+22.51% 263B
-1.76%+2.37%-20.43%-38.00% 223B
-1.42%+0.80%+24.27%+57.50% 198B
-1.48%+3.43%+24.08%+71.67% 167B
Average -0.13%+0.62%+29.04%+48.26% 357.6B
Weighted average by Cap. +0.37%+0.02%+37.51%+79.61%

Financials

2026 *2027 *
Net sales 14.88B 443M 388M 358M 329M 620M 42.66B 635M 4.27B 1.68B 20.89B 1.66B 1.63B 72.75B 15.61B 465M 407M 376M 346M 651M 44.77B 667M 4.49B 1.77B 21.92B 1.75B 1.71B 76.34B
Net income 2.32B 69.11M 60.46M 55.81M 51.36M 96.73M 6.65B 99.09M 667M 262M 3.26B 260M 254M 11.34B 2.46B 73.28M 64.1M 59.18M 54.46M 103M 7.05B 105M 707M 278M 3.45B 275M 269M 12.03B
Net Debt -4.61B -137M -120M -111M -102M -192M -13.23B -197M -1.33B -522M -6.48B -516M -505M -22.55B -4.76B -142M -124M -114M -105M -198M -13.64B -203M -1.37B -538M -6.68B -532M -520M -23.26B
Logo Mega Lifesciences
Mega Lifesciences Public Company Limited is a Thailand-based company, which is engaged in health and wellness industry. Its segments include Brands, Distribution and OEM. MEGA We Care is its branded products business, through which it develops, manufactures, markets and sells its own range of nutraceuticals, complementary medicines, prescription pharmaceuticals and over the counter (OTC) health products. Maxxcare serves as its prominent distribution arm, specializing in the marketing, sales, and distribution of a range of branded prescription pharmaceuticals, OTC medications and fast-moving consumer goods (FMCG) across key markets such as Myanmar, Vietnam and Cambodia. Its suite of services encompasses warehouse management, collections and value-added initiatives, including tailored marketing services for principals in the pharmaceutical and FMCG sectors. Its manufacturing facilities in Thailand, Australia and Indonesia also accept production orders from various third-party customers.
Employees
-
Date Price Change Volume
17/07/26 THB 37.75 -0.66% 575,076
16/07/26 THB 38.00 0.00% 211,213
15/07/26 THB 38.00 +0.66% 873,912
14/07/26 THB 37.75 +1.34% 737,163
13/07/26 THB 37.25 +0.68% 700,210
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
37.75THB
Average target price
41.14THB
Spread / Average Target
+8.99%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MEGA Stock